BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10717800)

  • 1. HLA matching in hematopoietic cell transplantation.
    Mickelson EM; Petersdorf E; Anasetti C; Martin P; Woolfrey A; Hansen JA
    Hum Immunol; 2000 Feb; 61(2):92-100. PubMed ID: 10717800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of unrelated donors for hematopoietic cell transplantation.
    Field T; Anasetti C
    Curr Hematol Rep; 2005 Jul; 4(4):270-5. PubMed ID: 16009041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.
    Petersdorf EW; Hansen JA; Martin PJ; Woolfrey A; Malkki M; Gooley T; Storer B; Mickelson E; Smith A; Anasetti C
    N Engl J Med; 2001 Dec; 345(25):1794-800. PubMed ID: 11752355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marrow transplantation from unrelated donors.
    Sierra J; Anasetti C
    Curr Opin Hematol; 1995 Nov; 2(6):444-51. PubMed ID: 9372034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of HLA matching on outcome of related and unrelated donor transplantation therapy for chronic myelogenous leukemia.
    Petersdorf E; Anasetti C; Servida P; Martin P; Hansen J
    Hematol Oncol Clin North Am; 1998 Feb; 12(1):107-21. PubMed ID: 9523228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry.
    Michallet M; Sobh M; Milligan D; Morisset S; Niederwieser D; Koza V; Ruutu T; Russell NH; Verdonck L; Dhedin N; Vitek A; Boogaerts M; Vindelov L; Finke J; Dubois V; van Biezen A; Brand R; de Witte T; Dreger P;
    Leukemia; 2010 Oct; 24(10):1725-31. PubMed ID: 20703257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.
    Davies SM; DeFor TE; McGlave PB; Miller JS; Verfaillie CM; Wagner JE; Weisdorf DJ
    Am J Med; 2001 Apr; 110(5):339-46. PubMed ID: 11286947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors.
    Morishima Y; Kawase T; Malkki M; Petersdorf EW;
    Tissue Antigens; 2007 Apr; 69 Suppl 1():31-5. PubMed ID: 17445159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Case for High Resolution Extended 6-Loci HLA Typing for Identifying Related Donors in the Indian Subcontinent.
    Agarwal RK; Kumari A; Sedai A; Parmar L; Dhanya R; Faulkner L
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1592-1596. PubMed ID: 28603069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia.
    Hongeng S; Krance RA; Bowman LC; Srivastava DK; Cunningham JM; Horwitz EM; Brenner MK; Heslop HE
    Lancet; 1997 Sep; 350(9080):767-71. PubMed ID: 9297996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.
    Sasazuki T; Juji T; Morishima Y; Kinukawa N; Kashiwabara H; Inoko H; Yoshida T; Kimura A; Akaza T; Kamikawaji N; Kodera Y; Takaku F
    N Engl J Med; 1998 Oct; 339(17):1177-85. PubMed ID: 9780337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of CML with unrelated donor marrow transplant.
    McGlave P
    Leuk Lymphoma; 1993; 11 Suppl 1():209-11. PubMed ID: 8251898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA matching for hematopoietic stem-cell transplants.
    Cooper DL
    N Engl J Med; 2002 Apr; 346(16):1251-2; author reply 1251-2. PubMed ID: 11961159
    [No Abstract]   [Full Text] [Related]  

  • 15. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
    Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
    Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
    Sun AN; Wu DP; Wang Y; Qiu HY; Jin ZM; Miao M; Tang XW; Fu ZZ; Ma X; Han Y; He GS; Chen SN; Xue SL; Zhao Y
    Ai Zheng; 2006 Aug; 25(8):1019-22. PubMed ID: 16965686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.
    Szydlo R; Goldman JM; Klein JP; Gale RP; Ash RC; Bach FH; Bradley BA; Casper JT; Flomenberg N; Gajewski JL; Gluckman E; Henslee-Downey PJ; Hows JM; Jacobsen N; Kolb HJ; Lowenberg B; Masaoka T; Rowlings PA; Sondel PM; van Bekkum DW; van Rood JJ; Vowels MR; Zhang MJ; Horowitz MM
    J Clin Oncol; 1997 May; 15(5):1767-77. PubMed ID: 9164184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized intervention guided by BCR-ABL transcript levels after HLA-identical sibling donor transplantation improves HSCT outcomes for patients with chronic myeloid leukemia.
    Huang XJ; Xu LP; Liu KY; Liu DH; Chen H; Liu YR; Chen YH; Han W; Wang Y
    Biol Blood Marrow Transplant; 2011 May; 17(5):649-56. PubMed ID: 20691800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry.
    Sullivan KM; Anasetti C; Horowitz M; Rowlings PA; Petersdorf EW; Martin PJ; Clift RA; Walters MC; Gooley T; Sierra J; Anderson JE; Bjerke J; Siadak M; Flowers ME; Nash RA; Sanders JE; Appelbaum FR; Storb R; Hansen JA
    Ann N Y Acad Sci; 1998 Jun; 850():312-24. PubMed ID: 9668553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA diversity: detection and impact on unrelated hematopoietic stem cell donor characterization and selection.
    Hurley CK
    Int J Hematol; 2002 Aug; 76 Suppl 2():152-4. PubMed ID: 12430917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.